Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
doi:10.1177/0897190013488802
Low total GSH and high homocysteine levels are considered as novel risk markers for acute stroke severity, and low total and reduced GSH levels may be potential risk markers for stroke severity and insufficient functional independence in large-artery atherosclerosis (157, 158)
Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition
Neurobiol Dis 2006
US$ 24.21
US$ 21.23
US$ 21.89
US$ 21.51
US$ 24.80
